November 18, 2026 · American heart journal · DOI: 10.1016/j.ahj.2026.107664

Design and rationale of MIRACLE, a prospective multicenter cohort study with integrated biobanking in cardiogenic shock.

Listen to this summary

MIRACLE is a prospective, multicenter German cohort that enrolls adults with cardiogenic shock or preshock of any cause (plus large anterior STEMI controls without shock), serially restaging SCAI stages and collecting repeated biobank samples through day 5 and 6-month follow-up. The study aims to characterize multimodal phenotypes and risk-stratify patients across shock etiologies, with 30-day all-cause mortality as the primary endpoint. As of September 2026, 449 shock/preshock patients had been enrolled, with 30-day mortality of 15% in SCAI B and 63% in SCAI E (35% overall).

Adrian Heidenreich, Annette Buellesbach, Diana Lindner, Roland Schmitz, Sebastian Ewen, Dennis Wolf, Christoph B Olivier, Alexandra Nieters, Kilian Franke, Tobias Wengenmayer, Uwe Zeymer, Till Keller, Dirk Westermann, Lucas Bacmeister

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play